However, in PAH, increased CD36-mediated fatty acid uptake, combined with impaired FAO, leads to lipid accumulation, thereby contributing to RV dysfunction and adverse metabolic outcomes [55,56,57]. This evidence concerns the gene CD36 and pulmonary arterial hypertension.